- March 10, 2021Acceptance of Clenafin/Jublia (efinaconazole) for Regulatory Review in China
- January 13, 2021License and Co-Development Agreement for a novel multispecific antibody candidate
- November 18, 2020The NHI Drug Reimbursement Price Listing and Launch of ECCLOCK? Gel 5% for the Treatment of Primary Axillary Hyperhidrosis
- September 25, 2020ECCLOCK? Gel 5% Approved in Japan for the Treatment of Primary Axillary Hyperhidrosis